Assessment of the albumin-bilirubin grade as a prognostic factor in patients with non-small-cell lung cancer receiving anti-PD-1-based therapy
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference57 articles.
1. Is there any place for PD-1/CTLA-4 inhibitors combination in the first-line treatment of advanced NSCLC? – A trial-level meta-analysis in PD-L1 selected subgroups;Passiglia;Transl Lung Cancer Res,2021
2. Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy;Cristescu;Science,2018
3. Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic;Chan;Ann Oncol,2019
4. High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types;McGrail;Ann Oncol,2021
5. The clinical utility of tumor mutational burden in non-small cell lung cancer;Greillier;Transl Lung Cancer Res,2018
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Association between albumin-bilirubin score and in-hospital mortality in patients with sepsis: Evidence from two large databases;Heliyon;2024-08
2. A novel liver-function-indicators-based prognosis signature for patients with hepatocellular carcinoma treated with anti-programmed cell death-1 therapy;Cancer Immunology, Immunotherapy;2024-06-04
3. Prognostic impact of FAN score in patients receiving nivolumab plus ipilimumab for metastatic renal cell carcinoma;Scientific Reports;2024-05-29
4. Comparing Laboratory Toxicity of Selective Intraarterial Radionuclide Therapy for Primary and Metastatic Liver Tumors: Resin versus Glass Microspheres;2024-05-29
5. Prognostic significance of pretreatment albumin–bilirubin (ALBI) grade and platelet–albumin–bilirubin (PALBI) grade in patients with small cell lung cancer;Scientific Reports;2024-01-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3